Participation of extracellular signal-regulated kinases 1/2 in osteoblast and adipocyte differentiation of mesenchymal stem cells grown on titanium surfaces

2017 ◽  
Vol 125 (5) ◽  
pp. 355-360 ◽  
Author(s):  
Heitor F. Silva ◽  
Rodrigo P. F. Abuna ◽  
Helena B. Lopes ◽  
Marcelo S. Francischini ◽  
Paulo T. de Oliveira ◽  
...  

2021 ◽  
Author(s):  
Ruriko Sekiya-Aoyama ◽  
Yoshinori Arisaka ◽  
Masahiro Hakariya ◽  
Hiroki Masuda ◽  
Takanori Iwata ◽  
...  

Mesenchymal stem cells on polyrotaxane surfaces underwent enhanced osteoblast and adipocyte differentiation. Two independent parameters, high molecular mobility and negative charge on the surfaces, may not offset the effect to promote both differentiation.



Bone ◽  
2006 ◽  
Vol 39 (1) ◽  
pp. 181-188 ◽  
Author(s):  
Basem M. Abdallah ◽  
Mandana Haack-Sørensen ◽  
Trine Fink ◽  
Moustapha Kassem


2018 ◽  
Vol 19 (7) ◽  
pp. 2081 ◽  
Author(s):  
Christian Carpéné ◽  
Héctor Pejenaute ◽  
Raquel del Moral ◽  
Nathalie Boulet ◽  
Elizabeth Hijona ◽  
...  

Phenolic compounds are among the most investigated herbal remedies, as is especially the case for resveratrol. Many reports have shown its anti-aging properties and the ability to reduce obesity and diabetes induced by high-fat diet in mice. However, such beneficial effects hardly translate from animal models to humans. The scientific community has therefore tested whether other plant phenolic compounds may surpass the effects of resveratrol. In this regard, it has been reported that piceatannol reproduces in rodents the anti-obesity actions of its parent polyphenol. However, the capacity of piceatannol to inhibit adipocyte differentiation in humans has not been characterized so far. Here, we investigated whether piceatannol was antiadipogenic and antilipogenic in human preadipocytes. Human mesenchymal stem cells (hMSC), isolated from adipose tissues of lean and obese individuals, were differentiated into mature adipocytes with or without piceatannol, and their functions were explored. Fifty μM of piceatannol deeply limited synthesis/accumulation of lipids in both murine and hMSC-derived adipocytes. Interestingly, this phenomenon occurred irrespective of being added at the earlier or later stages of adipocyte differentiation. Moreover, piceatannol lowered glucose transport into adipocytes and decreased the expression of key elements of the lipogenic pathway (PPARγ, FAS, and GLUT4). Thus, the confirmation of the antiadipogenic properties of piceatanol in vitro warrants the realization of clinical studies for the application of this compound in the treatment of the metabolic complications associated with obesity.



Neuroreport ◽  
2005 ◽  
Vol 16 (12) ◽  
pp. 1357-1361 ◽  
Author(s):  
Sung-Soo Kim ◽  
Jung-Mi Choi ◽  
Ji-Won Kim ◽  
Dong-Sik Ham ◽  
Sung-Ho Ghil ◽  
...  




2018 ◽  
Vol 4 (8) ◽  
pp. 2986-2993 ◽  
Author(s):  
Yiping Huang ◽  
Yunfei Zheng ◽  
Yongxiang Xu ◽  
Xiaobei Li ◽  
Yan Zheng ◽  
...  


2018 ◽  
Vol 500 (3) ◽  
pp. 682-690 ◽  
Author(s):  
Vuong Cat Khanh ◽  
Amin Firman Zulkifli ◽  
Chiho Tokunaga ◽  
Toshiharu Yamashita ◽  
Yuji Hiramatsu ◽  
...  


2019 ◽  
Vol 127 (3) ◽  
pp. 196-209
Author(s):  
Mingyue Lyu ◽  
Yunfei Zheng ◽  
Lingfei Jia ◽  
Yan Zheng ◽  
Yanping Liu ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document